Medical advances in the treatment of metastatic breast cancer

Hear about drugs that have been approved for metastatic breast cancer over the last 2 years and how they impact each subtype of breast cancer. Learn how these latest approvals compare with previous standard-of-care therapies, what we know, and what we don’t, and hear about the exciting drugs and approaches in the pipeline for the next 3 to 5 years.
Speaker: Maryam Lustberg, MD, MPH
To learn more about Thriving Together: 2024 Conference on Metastatic Breast Cancer visit www.lbbc.org/c...

[@annitafonken5498]

Theres been talk about that dosing should be worked out from the beginning of clinical trials.